HTG Molecular Diagnostics to Present at H.C. Wainwright’s 23rd Annual Global Investment Conference
September 08, 2021 16:10 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Sept. 08, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that...
HTG Molecular Diagnostics Reports Second Quarter 2021 Results
August 12, 2021 16:05 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Aug. 12, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its...
HTG’s New HTG Transcriptome Panel Launched with Commercial Availability in the U.S. and Europe
August 05, 2021 08:00 ET
|
HTG Molecular Diagnostics, Inc.
HTG Transcriptome Panel designed to measure approximately 20,000 mRNA targets using the HTG EdgeSeq technology Intended to serve as one of the technological cornerstones for the recently announced...
HTG Molecular Diagnostics to Announce Second Quarter 2021 Financial Results and Host Conference Call on Thursday, August 12
August 03, 2021 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Aug. 03, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will...
HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 23, 2021 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., July 23, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that, on...
HTG Forms New Drug Discovery Business Unit
July 20, 2021 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., July 20, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the...
HTG Receives First Commercial Orders for its Planned HTG Transcriptome Panel and Announces the Signing of Two European Early Adopter Program Agreements
June 22, 2021 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., June 22, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has...
HTG Completes Product Design Lock for its Planned Transcriptome Panel and Announces the Signing of the Three Early Adopter Program Collaboration Agreements
June 14, 2021 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., June 14, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has...
HTG EdgeSeq Technology Highlighted in Several Posters Being Presented at the American Society of Clinical Oncology 2021 Virtual Conference
May 24, 2021 16:11 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., May 24, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that its...
HTG Molecular Diagnostics Reports First Quarter 2021 Results and Provides a Corporate Update
May 13, 2021 16:05 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., May 13, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its...